Cellect Bio up 20% premarket enhanced ApoTainer process

|About: Cellect Biotechnology ... (APOP)|By:, SA News Editor

Thinly traded nano cap Cellect Biotechnology (NASDAQ:APOP) is up 20% premarket on average volume following its announcement of a new technology that it says maximizes the scalability and efficacy of ApoTainer manufacturing.

The breakthrough pertains to optimized FasL-coated magnetic beads that produce a dramatic increase in the interactions between the selecting agent and the cells. The company says the enhancement is significantly more efficient and cost-effective than current methods of cell selection (for example, T cell depletion), adding that donated stem cells can be transplantable in less than six hours in a simple bedside process.

Subscribe for full text news in your inbox